| Objective:To synthesize a mitochondria-targeting water-soluble indocyanine fluorescent small molecule(designated as PEG-808-NM2)via PEG modification and explore its radiotherapy sensitization effect in renal cell carcinoma as well as underlying mechanism.Methods:PEG-808-NM2 was chemically designed using 2,3,3-trimethylindole,2-nitroimidazole,and polyethylene glycol monomethyl ether as the starting materials(molar ratio 1:1:1.5)and synthesized via a six-step reaction.The successful synthesis of PEG-808-NM2 and other chemical intermediates were characterized using 1H nuclear magnetic resonance(NMR)and high-resolution mass spectrometry.UV-vis-NIR spectra and fluorescence spectra analysis also used to confirm the photophysical properties of PEG-808-NM2.The biosafety assessment of PEG-808-NM2 was evaluated using hemolysis assay and H&E staining of histological slices from vital organs.The cancer-targeting ability were validated by comparing the cell uptake of PEG-808-NM2 by normal renal tubular epithelial cells(HK-2)and renal cell carcinoma cells(RENCA).Subcellular localization of PEG-808-NM2 in mitochondrial were observed using fluorescence confocal microscopy after staining with a mitochondrial tracker(Mito Tracker).The synergistic effects of PEG-808-NM2 with radiotherapy were verified through evaluating cell viability,colony formation ability,intracellular ROS level,DNA damage,and tumour growth.Results:(1)The polyethylene glycol modified indocyanine molecule was synthesized by chemical reaction,and its structure was characterized by ~1H NMR and mass spectrometry,indicating that nitroimidazole and polyethylene glycol were introduced into the indocyanine molecule.(2)The UV-vis spectra absorption results demonstrated that 808-NM2 in PBS exhibits obvious double absorption peaks(680 nm and c).In contrast,PEG-808-NM2 only present the same absorption peak at 780 nm,indicating PEG modification could effectively increase the solubility and stability of 808-NM2.(3)Fluorescence confocal microscopy images revealed preferential PEG-808-NM2accumulation renal cancer cells RENCA than those in normal HK-2 cells(P<0.01),indicating the excellent tumor-targeting capability.Moreover,the fluorescence signals of PEG-808-NM2 in RENCA cells were obviously higher than 808-NM2 at same condition(P<0.01).(4)Subcellular localization analysis of PEG-808-NM2 in RENCA cells revealed the high degree(near 100%)overlap of green fluorescence signal(mitochondria-tracker)and red fluorescence signal(PEG-808-NM2)(5)In contrast to irradiated cells with 90%cell viability,>40%of irradiated cells were killed when treated with PEG-808-NM2(P<0.01).(6)Flow cytometry analysis demonstrated cell apoptosis in combined group was 26.1%,while 8.5%in irradiated cells.(7)Comet assay results showed the tail DNA content in combination treatment group was 80%,which is 2 times higher than in irradiation group(40%)(P<0.05).(8)Single-click multi-target model analysis demonstrated that the sensitizer enhancement ratio(SER)value was nearly 1.40,indicating the excellent radio-sensitization effect of PEG-808-NM2.(9)Hemolysis analysis also evidenced PEG-808-NM2 exhibited excellent hemocompatibility as no detectable hemolysis was found even at a relative high concentration(2μg/m L).(10)H&E staining of the main organs(heart,liver,spleen,lung,and kidney)did not reveal any abnormalities compared with control.In the treatment experimental group,the drug plus irradiation group had a significant inhibitory effect on the tumor compared with the simple irradiation group(P<0.05).Conclusion:(1)PEG modification of 808-NM2 could effectively improve the 808-NM2 and stability.(2)PEG-808-NM2 could preferentially accumulate in cancer cells and exhibit excellent mitochondria targeting capability.(3)PEG-808-NM2 exhibits excellent biocompatibility without obvious systemic toxicity.(4)PEG-808-NM2 could effectively suppress tumor growth synergistically by radiotherapy in vitro and vivo.(5)NIR fluorescent imaging property also can be used to precisely distinguish the tumors from their boundaries. |